• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肠易激综合征的病例对照研究中,健康对照受试者的定义不明确。

Healthy control subjects are poorly defined in case-control studies of irritable bowel syndrome.

作者信息

Ghorbani Shireen, Nejad Amir, Law David, Chua Kathleen S, Amichai Meridythe M, Pimentel Mark

机构信息

GI Motility Program, Cedars-Sinai Medical Center, Los Angeles (Shireen Ghorbani, Amir Nejad, Kathleen S. Chua, Meridythe M. Amichai, Mark Pimentel), California, USA.

Harbor UCLA Medical Center, Torrance (David Law), California, USA.

出版信息

Ann Gastroenterol. 2015 Jan-Mar;28(1):87-93.

PMID:25609236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4290009/
Abstract

BACKGROUND

Case-control studies are vital for understanding the pathophysiology of gastrointestinal disease. While the definition of disease is clear, the definition of healthy control is not. This is particularly relevant for functional bowel diseases such as irritable bowel syndrome (IBS). In this study, a systematic review formed the basis for a prospective study evaluating the effectiveness of commonly used techniques for defining healthy controls in IBS.

METHODS

A systematic review of the literature was conducted to identify case-control studies involving functional gastrointestinal disorders. "Lack of Rome criteria", self-description as "healthy" and the bowel disease questionnaire (BDQ) were common methods for identifying healthy controls. These 3 methods were then applied to a cohort of 53 non-patient subjects to determine their validity compared to objective outcome measures (7-day stool diary).

RESULTS

"Lack of Rome criteria" and "healthy" self-description were the most common methods for identifying healthy control subjects, but many studies failed to describe the methods used. In the prospective study, more subjects were identified as non-healthy using the BDQ than using either lack of Rome criteria (P=0.01) or "healthy" self-description (P=0.026). Furthermore, stool diaries identified several subjects with abnormal stool form and/or frequency which were not identified using lack of Rome criteria or the "healthy" question. Comparisons revealed no agreement (κ) between the different methods for defining healthy controls.

CONCLUSIONS

The definitions of healthy controls in studies of functional bowel diseases such as IBS are inconsistent. Since functional symptoms are common, a strict definition of "normal" is needed in this area of research.

摘要

背景

病例对照研究对于理解胃肠道疾病的病理生理学至关重要。虽然疾病的定义很明确,但健康对照的定义却不明确。这对于诸如肠易激综合征(IBS)等功能性肠病尤为重要。在本研究中,一项系统评价为一项前瞻性研究奠定了基础,该前瞻性研究评估了在IBS中定义健康对照的常用技术的有效性。

方法

对文献进行系统评价,以确定涉及功能性胃肠疾病的病例对照研究。“缺乏罗马标准”、自我描述为“健康”以及肠道疾病问卷(BDQ)是识别健康对照的常用方法。然后将这三种方法应用于53名非患者受试者的队列中,以与客观结果测量(7天大便日记)相比确定其有效性。

结果

“缺乏罗马标准”和“健康”自我描述是识别健康对照受试者最常用的方法,但许多研究未能描述所使用的方法。在前瞻性研究中,使用BDQ识别出的非健康受试者比使用缺乏罗马标准(P = 0.01)或“健康”自我描述(P = 0.026)识别出的更多。此外,大便日记识别出了几名大便形状和/或频率异常的受试者,而这些受试者使用缺乏罗马标准或“健康”问题未被识别。比较显示,不同的健康对照定义方法之间没有一致性(κ)。

结论

在诸如IBS等功能性肠病研究中,健康对照的定义不一致。由于功能症状很常见,因此在该研究领域需要对“正常”进行严格定义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbcd/4290009/644ad2db80be/AOG-28-87-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbcd/4290009/644ad2db80be/AOG-28-87-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbcd/4290009/644ad2db80be/AOG-28-87-g002.jpg

相似文献

1
Healthy control subjects are poorly defined in case-control studies of irritable bowel syndrome.在肠易激综合征的病例对照研究中,健康对照受试者的定义不明确。
Ann Gastroenterol. 2015 Jan-Mar;28(1):87-93.
2
Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.罗马 III 标准与罗马 IV 标准诊断肠易激综合征:一项大样本队列研究的临床特征比较。
Neurogastroenterol Motil. 2018 Feb;30(2). doi: 10.1111/nmo.13189. Epub 2017 Aug 14.
3
Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.用于评估临床试验中治疗效果的肠易激综合征症状日记的开发:基础定性研究。
Value Health. 2017 Apr;20(4):618-626. doi: 10.1016/j.jval.2016.11.001. Epub 2017 Jan 3.
4
Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.量化罗马症状用于肠易激综合征的诊断。
Neurogastroenterol Motil. 2018 Sep;30(9):e13356. doi: 10.1111/nmo.13356. Epub 2018 Apr 27.
5
A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator.女性肠易激综合征排便习惯的前瞻性评估:定义交替型。
Gastroenterology. 2005 Mar;128(3):580-9. doi: 10.1053/j.gastro.2004.12.006.
6
Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?肠易激综合征患者不同节段的传输时间与“正常”结肠传输时间:与症状是否存在关联?
Tech Coloproctol. 2006 Dec;10(4):287-96. doi: 10.1007/s10151-006-0295-9. Epub 2006 Nov 27.
7
Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.腹泻在评估肠易激综合征临床研究中便秘的重要性。
J Clin Gastroenterol. 2011 Oct;45(9):790-3. doi: 10.1097/MCG.0b013e3182053cea.
8
Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.验证罗马 III 标准在二级医疗机构中对肠易激综合征的诊断价值。
Gastroenterology. 2013 Dec;145(6):1262-70.e1. doi: 10.1053/j.gastro.2013.08.048. Epub 2013 Aug 28.
9
Irritable bowel syndrome: which definitions are consistent?肠易激综合征:哪些定义是一致的?
J Intern Med. 1998 Dec;244(6):489-94.
10
Agreement between prospective diary data and retrospective questionnaire report of abdominal pain and stooling symptoms in children with irritable bowel syndrome.肠易激综合征患儿腹痛和排便症状的前瞻性日记数据与回顾性问卷调查结果的一致性
Neurogastroenterol Motil. 2015 Aug;27(8):1110-9. doi: 10.1111/nmo.12590. Epub 2015 May 28.

引用本文的文献

1
Consensus Definition of Blood Samples from the Subcategorized Normal Controls in the Korea Biobank Network.韩国生物样本库网络中分类正常对照的血液样本的共识定义。
J Clin Med. 2023 Apr 24;12(9):3080. doi: 10.3390/jcm12093080.
2
Irritable Bowel Syndrome Is Not Associated with an Increased Risk of Polyps and Colorectal Cancer: A Systematic Review and Meta-Analysis.肠易激综合征与息肉和结直肠癌风险增加无关:系统评价和荟萃分析。
Dig Dis Sci. 2023 Jun;68(6):2585-2596. doi: 10.1007/s10620-023-07885-6. Epub 2023 Mar 4.
3
The gastrointestinal and microbiome impact of a resistant starch blend from potato, banana, and apple fibers: A randomized clinical trial using smart caps.

本文引用的文献

1
Diagnosing irritable bowel syndrome: a changing clinical paradigm.肠易激综合征的诊断:不断变化的临床范式
South Med J. 2011 Mar;104(3):195-9. doi: 10.1097/SMJ.0b013e31820bfb6c.
2
The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.符合罗马 III 标准的肠易激综合征患者中乳糜泻的患病率。
Eur J Intern Med. 2010 Oct;21(5):389-92. doi: 10.1016/j.ejim.2010.06.004. Epub 2010 Jul 14.
3
Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?
来自土豆、香蕉和苹果纤维的抗性淀粉混合物对胃肠道和微生物群的影响:一项使用智能胶囊的随机临床试验
Front Nutr. 2022 Sep 29;9:987216. doi: 10.3389/fnut.2022.987216. eCollection 2022.
4
Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.肌痛性脑脊髓炎/慢性疲劳综合征睡眠特征的系统评价
Healthcare (Basel). 2021 May 11;9(5):568. doi: 10.3390/healthcare9050568.
5
Biomarkers of Irritable Bowel Syndrome.肠易激综合征的生物标志物
J Neurogastroenterol Motil. 2017 Jan 30;23(1):20-26. doi: 10.5056/jnm16135.
6
Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.利福昔明治疗对肠易激综合征相关粪便微生物组和代谢组差异的有限长期影响。
Gut Microbes. 2016 Sep 2;7(5):397-413. doi: 10.1080/19490976.2016.1215805. Epub 2016 Jul 26.
7
Gene polymorphisms associated with functional dyspepsia.与功能性消化不良相关的基因多态性。
World J Gastroenterol. 2015 Jul 7;21(25):7672-82. doi: 10.3748/wjg.v21.i25.7672.
炎症性肠病患者的肠易激综合征样症状:真实关联还是隐匿性炎症的反映?
Am J Gastroenterol. 2010 Aug;105(8):1788, 1789-94; quiz 1795. doi: 10.1038/ajg.2010.156. Epub 2010 Apr 13.
4
Central processing of noxious somatic stimuli in patients with irritable bowel syndrome compared with healthy controls.肠易激综合征患者与健康对照者伤害性躯体刺激的中枢处理比较。
Clin J Pain. 2010 Feb;26(2):104-9. doi: 10.1097/AJP.0b013e3181bff800.
5
Lower functional gastrointestinal disorders: evidence of abnormal colonic transit in a 287 patient cohort.下胃肠道功能性疾病:287 例患者队列中结肠传输异常的证据。
Neurogastroenterol Motil. 2010 Mar;22(3):293-e82. doi: 10.1111/j.1365-2982.2009.01442.x. Epub 2009 Dec 21.
6
Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome.进食对健康人和肠易激综合征患者回肠-结肠和结肠传输的影响。
Dig Dis Sci. 2010 Feb;55(2):384-91. doi: 10.1007/s10620-009-1041-8.
7
Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome.健康受试者和肠易激综合征患者餐后小肠水含量的变化。
Gastroenterology. 2010 Feb;138(2):469-77, 477.e1. doi: 10.1053/j.gastro.2009.10.055. Epub 2009 Nov 10.
8
Do stool form and frequency correlate with whole-gut and colonic transit? Results from a multicenter study in constipated individuals and healthy controls.粪便形态和频率与全胃肠道和结肠传输是否相关?在便秘患者和健康对照者的多中心研究结果。
Am J Gastroenterol. 2010 Feb;105(2):403-11. doi: 10.1038/ajg.2009.612. Epub 2009 Nov 3.
9
Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome.肠易激综合征中的促炎细胞因子基因多态性。
J Clin Immunol. 2010 Jan;30(1):74-9. doi: 10.1007/s10875-009-9342-4. Epub 2009 Oct 21.
10
A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.肠易激综合征患者粪便和黏膜细菌群落的分子分析。
Dig Dis Sci. 2010 Feb;55(2):392-7. doi: 10.1007/s10620-009-0934-x. Epub 2009 Aug 20.